Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis
Open Access
- 21 June 2013
- journal article
- Published by Springer Science and Business Media LLC in Diagnostic Pathology
- Vol. 8 (1), 102
- https://doi.org/10.1186/1746-1596-8-102
Abstract
Objective Involvements of microRNA-22 (miR-22) in cancer development have attracted much attention, but its role in tumorigenesis of gastric cancer is still largely unknown. Therefore, the aim of this study was to investigate the expression patterns and clinical implications of miR-22 in gastric cancer. Methods Quantitative RT-PCR was performed to evaluate the expression levels of miR-22 in 98 pairs of gastric cancer and normal adjacent mucosa. Results Compared with normal adjacent mucosa, miR-22 expression was significantly downregulated in gastric cancer tissues (P < 0.001). Of 98 patients with gastric cancer, 58 (59.2%) were placed in the low miR-22 expression group and 40 (40.8%) were placed in the high miR-22 expression group. In addition, tumors with low miR-22 expression had greater extent of lymph node metastasis (P = 0.02) and distant metastasis (P = 0.01), and were at a worse stage (P = 0.01) than the tumors with high miR-22 expression. Moreover, the gastric cancer patients with low miR-22 expression had shorter overall survival than those with high miR-22 expression (P = 0.03). MiR-22, determined by multivariate analysis, was an independent prognostic factor for patients with gastric cancer. Conclusion Our data offer the convincing evidence that the reduced expression of miR-22 was significantly associated with malignant development of gastric cancer and may be a novel prognostic marker of this disease. miR-22 might have potentials in the application of cancer therapy for patients with gastric cancer.Keywords
This publication has 25 references indexed in Scilit:
- HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese populationDiagnostic Pathology, 2013
- Correlation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancerDiagnostic Pathology, 2013
- Differentiated embryonic chondrocyte-expressed gene 1 is associated with hypoxia-inducible factor 1α and Ki67 in human gastric cancerDiagnostic Pathology, 2013
- Ezrin overexpression predicts the poor prognosis of gastric adenocarcinomaDiagnostic Pathology, 2012
- Targeted Deletion of MicroRNA-22 Promotes Stress-Induced Cardiac Dilation and Contractile DysfunctionCirculation, 2012
- The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarraysDiagnostic Pathology, 2012
- microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicityBritish Journal of Cancer, 2010
- Identification of the miR-106b ~ 25 MicroRNA Cluster as a Proto-Oncogenic PTEN -Targeting Intron That Cooperates with Its Host Gene MCM7 in TransformationScience Signaling, 2010
- Integrative MicroRNA and Proteomic Approaches Identify Novel Osteoarthritis Genes and Their Collaborative Metabolic and Inflammatory NetworksPLOS ONE, 2008
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006